| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 42201 | Strategic Integrated Projects - Climate Action Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy,... | Grant Cash Grant | Europe | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy, and mechanisms established to ensure full implementation of the plan/strategy.After the project: Full implementation of the plan/strategy. In relation to those expected impacts, applicants are expected to define, calculate, explain and achieve the expected impacts as described in Award criterion ‘Impact’ of the full proposal evaluation (see Call document).Objective:Target the implementation of one or more of the following plans/strategies: Final updated National Energy and Climate Plans (NECP) and Long-Term Strategies (LTS) pursuant to Regulation on the governance of the energy union and climate action (EU) 2018/1999.National adaptation strategies and plans pursuant to Article 5 of the Regulation 2021/1119 (‘European Climate Law’), or regional adaptation strat... |
||||||
| 42202 | Strategic Nature Projects Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy,... | Grant Cash Grant | Europe | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy, and mechanisms established to ensure full implementation of the plan/strategy.After the project: Full implementation of the plan/strategy. In relation to those expected impacts, applicants are expected to define, calculate, explain and achieve the expected impacts as described in Award criterion ‘Impact’ of the full proposal evaluation (see Call document).Objective:Support the full implementation of the following plans and strategies:The Prioritised Action Frameworks (PAFs) pursuant to Article 8 of Council Directive 92/43/EEC on the conservation of natural habitats and of wild fauna and flora (the Habitats Directive) and;National restoration plans pursuant to Article 14 of Regulation (EU) 2024/1991 of the European Parliament and the Council on nature restorati... |
||||||
| 42203 | Portugal – Cleaning services – Aquisição de serviços de Limpeza e Higienização de Edificios Municipais Buyer: Município de Vale de Cambra | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2027-03-04 | Tender Procurement Contract | Portugal | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Município de Vale de Cambra | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2027-03-04 |
||||||
| 42204 | Understanding and avoiding maladaptation to climate change Expected Outcome:Project results are expected to contribute to all of the following outcomes:Existing evidence on maladaptation is... | Research Funding Cash Grant | Europe | Expected EU contribution: 5,000,000 EUR - 6,000,000 EUR | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to all of the following outcomes:Existing evidence on maladaptation is retrieved comprehensively, and new knowledge is generated for incorporation into main EU repositories, such as Climate-ADAPT or the portal of the EU Mission on Adaptation to Climate Change;The risk and adaptation assessment frameworks are improved by better integrating the maladaptation dimension;Guidelines and tools for maladaptation prevention and correction strategies are made available to adaptation stakeholders at relevant scales and inform the design and implementation of adaptation strategies and plans of the EU and Member States. Scope:Recent climate records, showing unprecedented temperatures and extreme weather events, underscore the urgent need for rapid, systemic and comprehensive adaptation to address the escalating impacts of climate change on a... |
||||||
| 42205 | Advancing understanding, modelling and prediction of extreme events in a changing climate Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Improved understanding of pa... | Research Funding Cash Grant | Europe | Expected EU contribution: 6,000,000 EUR - 6,000,000 EUR | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Improved understanding of past and present extreme events in the context of climate change in Europe and globally, as well as the interaction between different hazards, their cumulative and/or cascading effects.Enhanced seamless prediction and projection modelling and attribution capabilities for extreme events and their likelihood to support preparedness, response and resilience to climate change by EU and national and regional actors. The EU Union Preparedness Strategy, the EU Adaptation Strategy and the European Climate Adaptation Plan can act as a guidance in these efforts.Up-to-date contributions towards latest climate science, risk assessments, adaptation strategies and policies and improved early warning systems for single and multi-hazard events. Scope:Climate change is intensify... |
||||||
| 42206 | Palaeoclimate science for a better understanding of Earth system dynamics Expected Outcome:Project results are expected to contribute to some of the following outcomes:Better process understanding of past... | Research Funding Cash Grant | Europe | Expected EU contribution: 7,000,000 EUR - 7,000,000 EUR | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to some of the following outcomes:Better process understanding of past climate changes at different time scales, their variability and interactions with ecosystems, leading to improved Earth system models;Future climate change scenarios produced in light of past changes in the Earth system, in particular warm climates/high sea-level situations, and abrupt transitions;Identification of thresholds in Earth system components and better characterisation of driving mechanisms and feedbacks that may be responsible for non-linear behaviours, including indicators of abrupt changes, and early warning signals within palaeoclimate records;Synthesis of climate variations that can serve as fundamental basis for IPCC assessments and benchmarks for model inter-comparisons. Scope:Palaeoclimatic (including geological, biological and ice-core) re... |
||||||
| 42207 | Strategic Integrated Projects - Environment Expected Impact:Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted... | Grant Cash Grant | Europe | Not provided on the source page. Please check the official source. | Open Mar 4, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Impact:Expected Impact:By the end of the project: at least substantial contribution to the implementation of the targeted plan/strategy, and mechanisms established to ensure full implementation of the plan/strategy.After the project: Full implementation of the plan/strategy. In relation to those expected impacts, applicants are expected to define, calculate, explain and achieve the expected impacts as described in Award criterion ‘Impact’ of the full proposal evaluation (see Call document).Objective:Support the full implementation of the following plans and strategies:- Circular Economy: National or Regional Circular Economy Action Plans, Strategies, Roadmaps or similar, which are officially approved, and which include specific and measurable actions, or targets, with a clear timeline and are in line with or complement the objectives of the EU Circular Economy Action Plan and, w... |
||||||
| 42208 | High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and sub... | Grant Cash Grant | United States | Award ceiling: $1,500,000 | Open Mar 5, 2027 Open | Grants.gov |
|
Source description
The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding. |
||||||
| 42209 | Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) The purpose of this Notice of Funding Opportunity (NOFO) is to support investigators who have the interest and capability to join... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | Grants.gov |
|
Source description
The purpose of this Notice of Funding Opportunity (NOFO) is to support investigators who have the interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. It is expected that applicants will have, in hand, the starting compounds (validated hits) for chemical optimization and bioassays for testing new analog compounds.Through this NOFO, NIH wishes to stimulate research in:Discovery and development of novel, small molecules for their potential use in understanding biological processes relevant to the missions of National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Eye Institute (NEI), and/or National Institute on Aging (NIA) andDiscovery and/or validation of novel, biological targets that will inform studies of brain disease mechanisms.Emphasis will be placed on projects that provide new insight into important disease-related biological targets and biological processes. |
||||||
| 42210 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-03 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42211 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-03 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42212 | Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-03 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42213 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42214 | Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Nordost. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42215 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Umeclidiniumbromid, ATC R03BB07 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42216 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Fluticason, ATC R03AK11 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42217 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vilanterol und Fluticasonfuroat, ATC R03AK10 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42218 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Formoterol und Aclidiniumbromid, ATC R03AL05 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42219 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Somatropin, ATC H01AC01 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42220 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fertigarzneimittel SMOFkabiven, ATC B05BA10 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42221 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Meropenem, ATC J01DH02 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42222 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1a (ausschl. z. intramuskulären Injektion), ATC L03AB07 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42223 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Aclidiniumbromid, ATC R03AL05 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42224 | Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tamsulosin + Solifenacin, ATC G04CA53 für die Zeit 01.05.2025 - 30.04.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||
| 42225 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Dexamethason und Gentamicin, ATC S01CA21 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 5, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-05 |
||||||